SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-18-000038
Filing Date
2018-01-05
Accepted
2018-01-05 16:05:44
Documents
3
Period of Report
2018-01-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk1820951.htm 8-K 22842
2 EXHIBIT 10.1 exhibit_10-1.htm EX-10.1 9948
3 image0.jpg GRAPHIC 37757
  Complete submission text file 0001178913-18-000038.txt   86401
Mailing Address 18 EAST 16TH STREET NEW YORK NY 10003
Business Address 18 EAST 16TH STREET NEW YORK NY 10003 646-233-1454
Artemis Therapeutics, Inc. (Filer) CIK: 0001062128 (see all company filings)

IRS No.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24431 | Film No.: 18513470
SIC: 2890 Miscellaneous Chemical Products